To close this knowledge gap and inform rational use of treatment for overweight or obese populations, we planned to perform a systematic review and network meta-analysis of all available randomized clinical trials to summarize and compare evidence regarding individual GLP1-RAs therapy on body composition and anthropometric indices among adult overweight or obese patients with or without diabetes. The gene discussed is GLP1R; the disease is diabetes mellitus.